# Personalised Hyperlipidaemia Therapies Guided by Pharmacogenomics

> **NCT06217523** · NA · UNKNOWN · sponsor: **National University of Singapore** · enrollment: 700 (estimated)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **OTHER:** Pharmacogenomics-directed Hyperlipidaemia Management

## Key facts

- **NCT ID:** NCT06217523
- **Lead sponsor:** National University of Singapore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2024-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06217523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06217523, "Personalised Hyperlipidaemia Therapies Guided by Pharmacogenomics". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06217523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*